CVS Health Corporation
CVS
$95.93
$1.111.17%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.66% | 7.87% | 6.66% | 6.21% | 4.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.66% | 7.87% | 6.66% | 6.21% | 4.75% |
| Cost of Revenue | 7.86% | 7.87% | 7.22% | 7.53% | 5.99% |
| Gross Profit | 6.44% | 7.88% | 3.13% | -1.67% | -2.54% |
| SG&A Expenses | 4.26% | 4.56% | 2.72% | 3.66% | 4.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.45% | 7.49% | 6.70% | 7.09% | 5.85% |
| Operating Income | 16.19% | 24.94% | 4.86% | -20.08% | -25.67% |
| Income Before Tax | -51.89% | -65.26% | -56.77% | -32.63% | -27.23% |
| Income Tax Expenses | -71.46% | -73.88% | 44.44% | -17.69% | -23.10% |
| Earnings from Continuing Operations | -44.64% | -62.32% | -91.46% | -37.69% | -28.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -19.44% | 42.86% | 583.33% | 400.00% | 224.14% |
| Net Income | -44.47% | -61.68% | -90.65% | -36.98% | -27.88% |
| EBIT | 16.19% | 24.94% | 4.86% | -20.08% | -25.67% |
| EBITDA | 10.50% | 15.92% | 3.45% | -13.94% | -18.25% |
| EPS Basic | -45.09% | -61.77% | -90.11% | -36.28% | -26.54% |
| Normalized Basic EPS | 16.31% | 25.97% | 12.87% | -14.36% | -20.53% |
| EPS Diluted | -45.80% | -62.25% | -90.29% | -36.30% | -26.40% |
| Normalized Diluted EPS | 16.14% | 25.98% | 13.01% | -14.25% | -20.40% |
| Average Basic Shares Outstanding | 0.85% | 0.64% | -0.16% | -0.90% | -1.62% |
| Average Diluted Shares Outstanding | 1.03% | 0.67% | -0.28% | -1.08% | -1.83% |
| Dividend Per Share | 0.00% | 0.00% | 2.31% | 4.72% | 7.26% |
| Payout Ratio | 0.82% | 1.63% | 9.94% | 0.65% | 0.46% |